Spineguard (PA:ALSGD) — Market Cap & Net Worth
Market Cap & Net Worth: Spineguard (ALSGD)
Spineguard (PA:ALSGD) has a market capitalization of $9.99 Million (€8.54 Million) as of September 23, 2026. Listed on the PA stock exchange, this France-based company holds position #27182 globally and #465 in its home market, demonstrating a -7.24% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Spineguard's stock price €0.09 by its total outstanding shares 93893758 (93.89 Million). Also see ALSGD current and non-current assets for a full breakdown of the balance sheet.
Spineguard Market Cap History: 2015 to 2026
Spineguard's market capitalization history from 2015 to 2026. Data shows change from $529.98 Million to $9.99 Million (-30.17% CAGR). Also see Spineguard operating cash flow efficiency for how efficiently the company converts equity into cash flow.
Spineguard Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Spineguard's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check today's stock price for Spineguard for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
5.24x
Spineguard's market cap is 5.24 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $529.98 Million | $6.23 Million | -$3.88 Million | 85.09x | N/A |
| 2016 | $478.04 Million | $7.46 Million | -$4.18 Million | 64.06x | N/A |
| 2017 | $355.09 Million | $8.17 Million | -$4.13 Million | 43.44x | N/A |
| 2018 | $81.41 Million | $7.58 Million | -$2.33 Million | 10.75x | N/A |
| 2019 | $25.65 Million | $6.83 Million | -$685.73K | 3.76x | N/A |
| 2020 | $137.80 Million | $4.85 Million | -$2.72 Million | 28.40x | N/A |
| 2021 | $120.20 Million | $4.41 Million | -$1.72 Million | 27.29x | N/A |
| 2022 | $61.53 Million | $5.60 Million | -$2.39 Million | 10.99x | N/A |
| 2023 | $21.65 Million | $4.31 Million | -$4.18 Million | 5.02x | N/A |
| 2024 | $24.37 Million | $4.65 Million | -$3.08 Million | 5.24x | N/A |
Competitor Companies of ALSGD by Market Capitalization
Companies near Spineguard in the global market cap rankings as of September 23, 2026. Review ALSGD tangible net assets ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Spineguard by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #124 globally with a market cap of $179.07 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #228 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #238 globally with a market cap of $105.17 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #239 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #124 | Abbott Laboratories | NYSE:ABT | $179.07 Billion | $102.98 |
| #228 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $91.75 |
| #238 | Stryker Corporation | NYSE:SYK | $105.17 Billion | $274.19 |
| #239 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Spineguard Historical Marketcap From 2015 to 2026
Between 2015 and today, Spineguard's market cap moved from $529.98 Million to $ 9.99 Million, with a yearly change of -30.17%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €9.99 Million | -9.90% |
| 2025 | €11.09 Million | -54.50% |
| 2024 | €24.37 Million | +12.58% |
| 2023 | €21.65 Million | -64.82% |
| 2022 | €61.53 Million | -48.81% |
| 2021 | €120.20 Million | -12.77% |
| 2020 | €137.80 Million | +437.14% |
| 2019 | €25.65 Million | -68.49% |
| 2018 | €81.41 Million | -77.07% |
| 2017 | €355.09 Million | -25.72% |
| 2016 | €478.04 Million | -9.80% |
| 2015 | €529.98 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 22nd, 2026 the market cap of Spineguard was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $9.99 Million USD |
| MoneyControl | $9.99 Million USD |
| MarketWatch | $9.99 Million USD |
| marketcap.company | $9.99 Million USD |
| Reuters | $9.99 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Spineguard
SpineGuard SA provides designs, develops, and markets medical devices for spine in France and internationally. The company offers PediGuard drilling instruments comprising straight, curved, cannulated, psifguard, and threaded PediGuard products; and DSG smart screw that allows for one step screw placement treatment. It also provides DSG (Dynamic Surgical Guidance) Connect app that allows collecti… Read more